Who has invested in Vivatides Therapeutics?

Qiming Venture Partners, Highlight Capital, TF Capital, Apricot Capital are named among the investors backing Vivatides Therapeutics.

Vivatides Therapeutics Funding: $54M Raised, Series A (2026)

Vivatides Therapeutics funding overview

Vivatides Therapeutics has raised $54M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2026. The round record for Vivatides Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Qiming Venture Partners, Highlight Capital, TF Capital, Apricot Capital. 4 distinct backers are named across the disclosed rounds.

Vivatides Therapeutics at a glance

Total raised: $54M
Latest round: Series A
Latest round date: April 2026
Notable investors: Qiming Venture Partners, Highlight Capital, TF Capital, Apricot Capital

Frequently asked about Vivatides Therapeutics funding

How much has Vivatides Therapeutics raised?: Vivatides Therapeutics has raised $54M in total disclosed funding across the rounds on record.
Who has invested in Vivatides Therapeutics?: Qiming Venture Partners, Highlight Capital, TF Capital, Apricot Capital are named among the investors backing Vivatides Therapeutics.
What was the latest Vivatides Therapeutics funding round?: The most recent disclosed round is a Series A, announced in April 2026.
Where is Vivatides Therapeutics based?: No headquarters location is disclosed for Vivatides Therapeutics.
When did Vivatides Therapeutics last raise?: The last disclosed Vivatides Therapeutics round closed in April 2026 at Series A.

Vivatides Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies below to benchmark round size and investor mix.

Vivatides Therapeutics Funding: $54M Raised, Series A (2026)

Vivatides Therapeutics funding overview

Vivatides Therapeutics at a glance

Frequently asked about Vivatides Therapeutics funding

Companies related to Vivatides Therapeutics (18)

Browse related funding lists (7)